Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 88


Recognition and Management of Hypertension in Older Persons: Focus on African Americans.

Still CH, Ferdinand KC, Ogedegbe G, Wright JT Jr.

J Am Geriatr Soc. 2015 Oct;63(10):2130-8. doi: 10.1111/jgs.13672. Review.


Use of Loop Diuretics is Associated with Increased Mortality in Patients with Suspected Coronary Artery Disease, but without Systolic Heart Failure or Renal Impairment: An Observational Study Using Propensity Score Matching.

Schartum-Hansen H, Løland KH, Svingen GF, Seifert R, Pedersen ER, Nordrehaug JE, Bleie Ø, Ebbing M, Berge C, Nilsen DW, Nygård O.

PLoS One. 2015 Jun 1;10(6):e0124611. doi: 10.1371/journal.pone.0124611. eCollection 2015.


Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy.

Ruilope LM, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, Remuzzi G, Rossing P, Schmieder RE, Nowack C, Ferreira AC, Pieper A, Kimmeskamp-Kirschbaum N, Bakris GL.

Am J Nephrol. 2014;40(6):572-81. doi: 10.1159/000371497. Epub 2015 Jan 10.


Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Muntner P, Davis BR, Cushman WC, Bangalore S, Calhoun DA, Pressel SL, Black HR, Kostis JB, Probstfield JL, Whelton PK, Rahman M; ALLHAT Collaborative Research Group.

Hypertension. 2014 Nov;64(5):1012-21. doi: 10.1161/HYPERTENSIONAHA.114.03850. Epub 2014 Aug 4.


The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).

Ambrosius WT, Sink KM, Foy CG, Berlowitz DR, Cheung AK, Cushman WC, Fine LJ, Goff DC Jr, Johnson KC, Killeen AA, Lewis CE, Oparil S, Reboussin DM, Rocco MV, Snyder JK, Williamson JD, Wright JT Jr, Whelton PK; SPRINT Study Research Group.

Clin Trials. 2014 Oct;11(5):532-46. doi: 10.1177/1740774514537404. Epub 2014 Jun 5.


Sex-specific acute heart failure phenotypes and outcomes from PROTECT.

Meyer S, van der Meer P, Massie BM, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison BA, Cleland JG, Givertz MM, Bloomfield DM, Fiuzat M, Dittrich HC, Hillege HL, Voors AA.

Eur J Heart Fail. 2013 Dec;15(12):1374-81. doi: 10.1093/eurjhf/hft115.


Incidence and predictors of end-stage renal disease in outpatients with systolic heart failure.

Bosselmann H, Gislason G, Gustafsson F, Hildebrandt PR, Videbaek L, Kober L, Torp-Pedersen C, Tonder N, Rossing K, Christensen S, Kamper AL, Heaf J, Schou M.

Circ Heart Fail. 2013 Nov;6(6):1124-31. doi: 10.1161/CIRCHEARTFAILURE.113.000553. Epub 2013 Oct 18.


Blood pressure elevation in hemodialysis patients after the Great East Japan Earthquake.

Tani Y, Nakayama M, Tanaka K, Hayashi Y, Asahi K, Kamata T, Ogihara M, Sato K, Matsushima M, Watanabe T.

Hypertens Res. 2014 Feb;37(2):139-44. doi: 10.1038/hr.2013.116. Epub 2013 Oct 3.


Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients?

Taber DJ, Srinivas TM, Pilch NA, Meadows HB, Fleming JN, McGillicuddy JW, Bratton CF, Thomas B, Chavin KD, Baliga PK, Egede LE.

Am J Nephrol. 2013;38(4):285-91. doi: 10.1159/000355135. Epub 2013 Sep 21.


[Diuretics in monotherapy and in combination with other diuretics and nondiuretics in the treatment of hypertension].

Spinar J, Spinarová L, Vítovec J.

Vnitr Lek. 2013 Jun;59(6):486-94. Review. Czech.


The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5.

Karunaratne K, Stevens P, Irving J, Hobbs H, Kilbride H, Kingston R, Farmer C.

Nephrol Dial Transplant. 2013 Aug;28(8):2107-16. doi: 10.1093/ndt/gft093. Epub 2013 May 7.


Combined olmesartan, amlodipine, and hydrochlorothiazide therapy in randomized patients with hypertension: a subgroup analysis of the TRINITY study by age.

Lewin AJ, Izzo JL Jr, Melino M, Lee J, Fernandez V, Heyrman R.

Drugs Aging. 2013 Jul;30(7):549-60. doi: 10.1007/s40266-013-0072-1.


Which is a better treatment for hypertensive patients with diabetes: a combination of losartan and hydrochlorothiazide or a maximum dose of losartan?

Nishimura H, Shintani M, Maeda K, Otoshi K, Fukuda M, Okuda J, Nishi S, Ohashi S, Kato S, Baba Y; Biriken Study Group.

Clin Exp Hypertens. 2013;35(8):582-8. doi: 10.3109/10641963.2013.776564. Epub 2013 Mar 15.


Utility of bioimpedance spectroscopy (BIS) in the management of refractory hypertension in patients with chronic kidney disease (CKD).

Verdalles U, de Vinuesa SG, Goicoechea M, Quiroga B, Reque J, Panizo N, Arroyo D, Luño J.

Nephrol Dial Transplant. 2012 Dec;27 Suppl 4:iv31-5. doi: 10.1093/ndt/gfs420.


Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial.

Shah SJ, Heitner JF, Sweitzer NK, Anand IS, Kim HY, Harty B, Boineau R, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Lewis EF, Markov V, O'Meara E, Kobulia B, Shaburishvili T, Solomon SD, Pitt B, Pfeffer MA, Li R.

Circ Heart Fail. 2013 Mar;6(2):184-92. doi: 10.1161/CIRCHEARTFAILURE.112.972794. Epub 2012 Dec 20.


Treatment of isolated systolic hypertension in the elderly.

Duprez D.

Expert Rev Cardiovasc Ther. 2012 Nov;10(11):1367-73. doi: 10.1586/erc.12.117. Review.


Combination therapy with losartan/hydrochlorothiazide for blood pressure reduction and goal attainment in a real-world clinical setting in Japan.

Suzuki H, Shimada Y, Fujiwara K.

Ther Adv Cardiovasc Dis. 2012 Dec;6(6):237-44. doi: 10.1177/1753944712464285. Epub 2012 Nov 5.


Effectiveness of antihypertensive drugs in hypertensive patients with end stage renal failure.

Kumolosasi E, Ng WB, Abdul Aziz SA.

Med J Malaysia. 2012 Aug;67(4):379-85.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk